肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
Author Correction: A therapeutic regimen using neoantigen-specific TCR-T cells for HLA-A*2402-positive solid tumors.
Programmable engineered bacteria manipulate metabolism and remodel the TME in situ for enhancing adoptive cell therapy.
Structure-Function Insights into Immune Receptors Drive Innovation in CAR-T Cell Therapy.
Targeting solid tumors with TCR-T cells: mechanisms, progress, and challenges.
De novo engineered disulfide bond supersedes native interchain linkage to enhance TCR pairing and anti-tumor efficacy in T cell therapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。